Douglas John Karas - 29 Dec 2023 Form 4 Insider Report for Nascent Biotech Inc.

Role
Director
Signature
/s/ Douglas Karas
Issuer symbol
NBIO on OTC
Transactions as of
29 Dec 2023
Net transactions value
+$5,208
Form type
4
Filing time
27 Feb 2024, 13:45:51 UTC
Previous filing
09 Nov 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $5,208 +28,935 +1.7% $0.1800* 1,744,452 29 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.